Importer of Controlled Substances Application: Fresenius Kabi USA, LLC, 83613-83614 [2020-28177]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 246 / Tuesday, December 22, 2020 / Notices
not entered an appearance as a party to
the investigations may submit a written
statement of information pertinent to
the subject of the investigations,
including statements of support or
opposition to the petition, on or before
February 25, 2021. On March 16, 2021,
the Commission will make available to
parties all information on which they
have not had an opportunity to
comment. Parties may submit final
comments on this information on or
before March 18, 2021, but such final
comments must not contain new factual
information and must otherwise comply
with § 207.30 of the Commission’s rules.
All written submissions must conform
with the provisions of § 201.8 of the
Commission’s rules; any submissions
that contain BPI must also conform with
the requirements of §§ 201.6, 207.3, and
207.7 of the Commission’s rules. The
Commission’s Handbook on Filing
Procedures, available on the
Commission’s website at https://
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf, elaborates
upon the Commission’s procedures with
respect to filings.
Additional written submissions to the
Commission, including requests
pursuant to § 201.12 of the
Commission’s rules, shall not be
accepted unless good cause is shown for
accepting such submissions, or unless
the submission is pursuant to a specific
request by a Commissioner or
Commission staff.
In accordance with §§ 201.16(c) and
207.3 of the Commission’s rules, each
document filed by a party to the
investigations must be served on all
other parties to the investigations (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
Authority: These investigations are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to § 207.21 of the Commission’s
rules.
jbell on DSKJLSW7X2PROD with NOTICES
By order of the Commission.
Issued: December 16, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–28140 Filed 12–21–20; 8:45 am]
BILLING CODE 7020–02–P
VerDate Sep<11>2014
17:30 Dec 21, 2020
Jkt 253001
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—CHEDE–8
Notice is hereby given that, on
December 15, 2020, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
CHEDE–8 (‘‘CHEDE–8’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Caterpillar, Inc., Peoria, IL, has been
added as a party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and CHEDE–8
intends to file additional written
notifications disclosing all changes in
membership.
On December 4, 2019, CHEDE–8 filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on December 30, 2019
(84 FR 71977).
The last notification was filed with
the Department on October 20, 2020. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on November 19, 2020 (85 FR
73751).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2020–28141 Filed 12–21–20; 8:45 am]
83613
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Australian Council for
Educational Research, Camberwell,
AUSTRALIA; ClassEDU Inc., Raleigh,
NC; GreenLight Credentials, Dallas, TX;
Magic Software Inc., New York, NY;
Manabie International Pte Ltd,
Singapore, SINGAPORE; Richland
School District No. 2, Columbia, SC; and
Virtual Virginia, Floyd, VA, have been
added as parties to this venture.
Also, IBM, Cambridge, MA; Paradigm,
Inc., Virginia Beach, VA; Badgewell,
Giza, EGYPT; VidGrid, St. Paul, MN;
and Unox Portal (Pragnya Technologies
Pty), Sydney, AUSTRALIA, have
withdrawn as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and IMS Global
intends to file additional written
notifications disclosing all changes in
membership.
On April 7, 2000, IMS Global filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on September 13, 2000 (65 FR
55283).
The last notification was filed with
the Department on September 16, 2020.
A notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on October 15, 2020 (85 FR 65426).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2020–28138 Filed 12–21–20; 8:45 am]
BILLING CODE 4410–11–P
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Antitrust Division
[Docket No. DEA–758]
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—IMS Global Learning
Consortium, Inc.
Importer of Controlled Substances
Application: Fresenius Kabi USA, LLC
Notice is hereby given that, on
December 3, 2020, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), IMS
Global Learning Consortium, Inc. (‘‘IMS
Global’’) has filed written notifications
simultaneously with the Attorney
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Fresenius Kabi USA, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTAL
INFORMATION listed below for further
drug information.
SUMMARY:
E:\FR\FM\22DEN1.SGM
22DEN1
83614
Federal Register / Vol. 85, No. 246 / Tuesday, December 22, 2020 / Notices
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 21, 2021. Such
persons may also file a written request
for a hearing on the application on or
before January 21, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on August 7, 2020,
Fresenius Kabi USA, LLC, 3159 Stanley
Road, Grand Island, New York 14072–
2028, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug
code
Schedule
Remifentanil ....................
9739
II
The company plans to import the
listed controlled substances for bulk
manufacture. No other activity for this
drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
jbell on DSKJLSW7X2PROD with NOTICES
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–28177 Filed 12–21–20; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
17:30 Dec 21, 2020
Jkt 253001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–740]
Importer of Controlled Substances
Application: Yourway Transport
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–28179 Filed 12–21–20; 8:45 am]
BILLING CODE P
Yourway Transport has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 21, 2021. Such
persons may also file a written request
for a hearing on the application on or
before January 21, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 24, 2020, Yourway
Transport, 6681 Snowdrift Road,
Allentown, Pennsylvania 18106,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUMMARY:
Controlled substance
Drug
code
Schedule
Marihuana .......................
7360
I
The company plans to import finished
dosage unit products containing
Marihuana for clinical trial studies. The
Marihuana compound is listed under
drug code 7360. No other activity for
this drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–757]
Importer of Controlled Substances
Application: Organic Standards
Solutions International, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Organic Standards Solutions
International, LLC has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTAL INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 21, 2021. Such
persons may also file a written request
for a hearing on the application on or
before January 21, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on October 30, 2020,
Organic Standards Solutions
International, LLC, 7290 Investment
Drive, Unit B, North Charleston, South
Carolina 29418–8305, applied to be
registered as an importer of the
DATES:
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 85, Number 246 (Tuesday, December 22, 2020)]
[Notices]
[Pages 83613-83614]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28177]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-758]
Importer of Controlled Substances Application: Fresenius Kabi
USA, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Fresenius Kabi USA, LLC has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
[[Page 83614]]
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before January 21,
2021. Such persons may also file a written request for a hearing on the
application on or before January 21, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on August 7, 2020, Fresenius Kabi USA, LLC, 3159 Stanley
Road, Grand Island, New York 14072-2028, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Remifentanil........................... 9739 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
bulk manufacture. No other activity for this drug code is authorized
for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-28177 Filed 12-21-20; 8:45 am]
BILLING CODE 4410-09-P
